• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Zydus Lifesciences Limited — Updates, 17-03-2026: Press Release

    17-03-2026 | 12:00 pm

    Zydus & Lupin partnered to co-market an innovative Semaglutide Injection in India for diabetes and weight management. Lupin gains semi-exclusive rights; Zydus receives upfront and milestone payments. This strengthens both companies' metabolic portfolios and expands patient access.

    No comments yet. Be the first to comment!

    All announcements from Zydus Lifesciences Limited